Skip to main content
PMC home page
Neuroscience Bulletin logoLink to Neuroscience Bulletin
. 2012 Jan 25;28(1):14–24. doi: 10.1007/s12264-012-1057-5

Caspase-3 activation as a bifurcation point between plasticity and cell death

Shikha Snigdha 1,✉, Erica D Smith 1, G Aleph Prieto 1, Carl W Cotman 1
PMCID: PMC3838299  NIHMSID: NIHMS521867  PMID: 22233886

Abstract

Death-mediating proteases such as caspases and caspase-3 in particular, have been implicated in neurodegenerative processes, aging and Alzheimer’s disease. However, emerging evidence suggests that in addition to their classical role in cell death, caspases play a key role in modulating synaptic function. It is remarkable that active caspases-3, which can trigger widespread damage and degeneration, aggregates in structures as delicate as synapses and persists in neurons without causing acute cell death. Here, we evaluate this dichotomy, and discuss the hypothesis that caspase-3 may be a bifurcation point in cellular signaling, able to orient the neuronal response to stress down either pathological/apoptotic pathways or towards physiological cellular remodeling. We propose that temporal, spatial and other regulators of caspase activity are key determinants of the ultimate effect of caspase-3 activation in neurons. This concept has implications for differential roles of caspase-3 activation across the lifespan. Specifically, we propose that limited caspase-3 activation is critical for synaptic function in the healthy adult brain while chronic activation is involved in degenerative processes in the aging brain.

Keywords: caspase-3, neurodegeneration, cognition, memory, synaptic function

References

  • [1].Du Y., Bales K.R., Dodel R.C., Hamilton-Byrd E., Horn J.W., Czilli D.L., et al. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc Natl Acad Sci U S A. 1997;94:11657–11662. doi: 10.1073/pnas.94.21.11657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Gillardon F., Kiprianova I., Sandkuhler J., Hossmann K.A., Spranger M. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia. Neuroscience. 1999;93:1219–1222. doi: 10.1016/S0306-4522(99)00292-4. [DOI] [PubMed] [Google Scholar]
  • [3].Earnshaw W.C., Samejima K., Svingen P.A., Basi G.S., Kottke T., Mesner P.W., et al. Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis. J Biol Chem. 1999;274:4335–4340. doi: 10.1074/jbc.274.7.4335. [DOI] [PubMed] [Google Scholar]
  • [4].Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 1999;6:1028–1042. doi: 10.1038/sj.cdd.4400598. [DOI] [PubMed] [Google Scholar]
  • [5].Fischer U., Janicke R.U., Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003;10:76–100. doi: 10.1038/sj.cdd.4401160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Hengartner M.O. The biochemistry of apoptosis. Nature. 2000;407:770–776. doi: 10.1038/35037710. [DOI] [PubMed] [Google Scholar]
  • [7].Kumar S. Caspase function in programmed cell death. Cell Death Differ. 2007;14:32–43. doi: 10.1038/sj.cdd.4402060. [DOI] [PubMed] [Google Scholar]
  • [8].Marks N., Berg M.J. Recent advances on neuronal caspases in development and neurodegeneration. Neurochem Int. 1999;35:195–220. doi: 10.1016/S0197-0186(99)00061-3. [DOI] [PubMed] [Google Scholar]
  • [9].Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A. 1999;96:10964–10967. doi: 10.1073/pnas.96.20.10964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Shi Y. Caspase activation: revisiting the induced proximity model. Cell. 2004;117:855–858. doi: 10.1016/j.cell.2004.06.007. [DOI] [PubMed] [Google Scholar]
  • [11].de Bilbao F., Guarin E., Nef P., Vallet P., Giannakopoulos P., Dubois-Dauphin M. Postnatal distribution of cpp32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridization study. J Comp Neurol. 1999;409:339–357. doi: 10.1002/(SICI)1096-9861(19990705)409:3<339::AID-CNE1>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  • [12].Yakovlev A.G., Ota K., Wang G., Movsesyan V., Bao W.L., Yoshihara K., et al. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci. 2001;21:7439–7446. doi: 10.1523/JNEUROSCI.21-19-07439.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Dash P.K., Blum S., Moore A.N. Caspase activity plays an essential role in long-term memory. Neuroreport. 2000;11:2811–2816. doi: 10.1097/00001756-200008210-00040. [DOI] [PubMed] [Google Scholar]
  • [14].Li Z., Jo J., Jia J.M., Lo S.C., Whitcomb D.J., Jiao S., et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell. 2010;141:859–871. doi: 10.1016/j.cell.2010.03.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Bachelder R.E., Ribick M.J., Marchetti A., Falcioni R., Soddu S., Davis K.R., et al. p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J Cell Biol. 1999;147:1063–1072. doi: 10.1083/jcb.147.5.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Belmokhtar C.A., Hillion J., Segal-Bendirdjian E. Staurosporine induces apoptosis through both caspase-dependent and caspaseindependent mechanisms. Oncogene. 2001;20:3354–3362. doi: 10.1038/sj.onc.1204436. [DOI] [PubMed] [Google Scholar]
  • [17].Jiao S., Li Z. Nonapoptotic function of BAD and BAX in long-term depression of synaptic transmission. Neuron. 2011;70:758–772. doi: 10.1016/j.neuron.2011.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Huesmann G.R., Clayton D.F. Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation. Neuron. 2006;52:1061–1072. doi: 10.1016/j.neuron.2006.10.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Jo J., Whitcomb D.J., Olsen K.M., Kerrigan T.L., Lo S.C., Bru-Mercier G., et al. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat Neurosci. 2011;14:545–547. doi: 10.1038/nn.2785. [DOI] [PubMed] [Google Scholar]
  • [20].Stepanichev M.Y., Kudryashova I.V., Yakovlev A.A., Onufriev M.V., Khaspekov L.G., Lyzhin A.A., et al. Central administration of a caspase inhibitor impairs shuttle-box performance in rats. Neuroscience. 2005;136:579–591. doi: 10.1016/j.neuroscience.2005.08.010. [DOI] [PubMed] [Google Scholar]
  • [21].D’Amelio M., Cavallucci V., Middei S., Marchetti C., Pacioni S., Ferri A., et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer’s disease. Nat Neurosci. 2011;14:69–76. doi: 10.1038/nn.2709. [DOI] [PubMed] [Google Scholar]
  • [22].Lesuisse C., Martin L.J. Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. J Cereb Blood Flow Metab. 2002;22:935–950. doi: 10.1097/00004647-200208000-00005. [DOI] [PubMed] [Google Scholar]
  • [23].Lynch A.M., Lynch M.A. The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur J Neurosci. 2002;15:1779–1788. doi: 10.1046/j.1460-9568.2002.02012.x. [DOI] [PubMed] [Google Scholar]
  • [24].Martin D.S., Lonergan P.E., Boland B., Fogarty M.P., Brady M., Horrobin D.F., et al. Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid. J Biol Chem. 2002;277:34239–34246. doi: 10.1074/jbc.M205289200. [DOI] [PubMed] [Google Scholar]
  • [25].Snigdha S., Berchtold N., Astarita G., Saing T., Piomelli D., Cotman C.W. Dietary and behavioral interventions protect against age related activation of caspase cascades in the canine brain. PLoS One. 2011;6:e24652. doi: 10.1371/journal.pone.0024652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Su J.H., Zhao M., Anderson A.J., Srinivasan A., Cotman C.W. Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathology. Brain Res. 2001;898:350–357. doi: 10.1016/S0006-8993(01)02018-2. [DOI] [PubMed] [Google Scholar]
  • [27].Jackson T.C., Rani A., Kumar A., Foster T.C. Regional hippocampal differences in AKT survival signaling across the lifespan: implications for CA1 vulnerability with aging. Cell Death Differ. 2009;16:439–448. doi: 10.1038/cdd.2008.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Nie K., Yu J.C., Fu Y., Cheng H.Y., Chen F.Y., Qu Y., et al. Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus. Biochem Biophys Res Commun. 2009;378:103–107. doi: 10.1016/j.bbrc.2008.11.010. [DOI] [PubMed] [Google Scholar]
  • [29].Andjelkovic M., Alessi D.R., Meier R., Fernandez A., Lamb N.J., Frech M., et al. Role of translocation in the activation and function of protein kinase B. J Biol Chem. 1997;272:31515–31524. doi: 10.1074/jbc.272.50.31515. [DOI] [PubMed] [Google Scholar]
  • [30].Bellacosa A., Chan T.O., Ahmed N.N., Datta K., Malstrom S., Stokoe D., et al. Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene. 1998;17:313–325. doi: 10.1038/sj.onc.1201947. [DOI] [PubMed] [Google Scholar]
  • [31].Song G., Ouyang G., Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005;9:59–71. doi: 10.1111/j.1582-4934.2005.tb00337.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Pastor M.D., García-Yébenes I., Fradejas N., Pérez-Ortiz J.M., Mora-Lee S., Tranque P., et al. mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia. J Biol Chem. 2009;284(33):22067–22078. doi: 10.1074/jbc.M109.033100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Condorelli F., Salomoni P., Cotteret S., Cesi V., Srinivasula S.M., Alnemri E.S., et al. Caspase cleavage enhances the apoptosis-inducing effects of BAD. Mol Cell Biol. 2001;21:3025–3036. doi: 10.1128/MCB.21.9.3025-3036.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282:1318–1321. doi: 10.1126/science.282.5392.1318. [DOI] [PubMed] [Google Scholar]
  • [35].Kato M., Yuan H., Xu Z.G., Lanting L., Li S.L., Wang M., et al. Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol. 2006;17:3325–3335. doi: 10.1681/ASN.2006070754. [DOI] [PubMed] [Google Scholar]
  • [36].Tong L., Balazs R., Soiampornkul R., Thangnipon W., Cotman C.W. Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging. 2008;29:1380–1393. doi: 10.1016/j.neurobiolaging.2007.02.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Tong L., Balazs R., Thornton P.L., Cotman C.W. Beta-amyloid peptide at sublethal concentrations down-regulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci. 2004;24:6799–6809. doi: 10.1523/JNEUROSCI.5463-03.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37–40. doi: 10.1038/35065000. [DOI] [PubMed] [Google Scholar]
  • [39].Guyton K.Z., Liu Y., Gorospe M., Xu Q., Holbrook N.J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem. 1996;271:4138–4142. doi: 10.1074/jbc.271.8.4138. [DOI] [PubMed] [Google Scholar]
  • [40].Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270:1326–1331. doi: 10.1126/science.270.5240.1326. [DOI] [PubMed] [Google Scholar]
  • [41].Yang J.Y., Michod D., Walicki J., Widmann C. Surviving the kiss of death. Biochem Pharmacol. 2004;68:1027–1031. doi: 10.1016/j.bcp.2004.03.043. [DOI] [PubMed] [Google Scholar]
  • [42].Allan L.A., Morrice N., Brady S., Magee G., Pathak S., Clarke P.R. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol. 2003;5:647–654. doi: 10.1038/ncb1005. [DOI] [PubMed] [Google Scholar]
  • [43].Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., et al. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem. 2000;275:12200–12206. doi: 10.1074/jbc.275.16.12200. [DOI] [PubMed] [Google Scholar]
  • [44].Bredesen D.E., Castro-Obregon S., Rao R.V., del Rio G., Chen S.F., Poksay K.S., et al. Alternative, nonapoptotic programmed cell death — Mediation by arrestin 2, ERK2, AND Nur77. J Biol Chem. 2004;279:17543–17553. doi: 10.1074/jbc.M312363200. [DOI] [PubMed] [Google Scholar]
  • [45].Zhao M., Su J., Head E., Cotman C.W. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer’s disease. Neurobiol Dis. 2003;14:391–403. doi: 10.1016/j.nbd.2003.07.006. [DOI] [PubMed] [Google Scholar]
  • [46].de Calignon A., Spires-Jones T.L., Hyman B.T. Caspase activation precedes and leads to neurodegeneration in a marine model of Alzheimer’s disease. Med Sci (Paris) 2010;26:787–789. doi: 10.1051/medsci/20102610787. [DOI] [PubMed] [Google Scholar]
  • [47].Shimohama S., Tanino H., Fujimoto S. Changes in caspase expression in Alzheimer’s disease: Comparison with development and aging. Biochem Biophys Res Commun. 1999;256:381–384. doi: 10.1006/bbrc.1999.0344. [DOI] [PubMed] [Google Scholar]
  • [48].Tesco G., Koh Y.H., Kang E.L., Cameron A.N., Das S., Sena-Esteves M., et al. Depletion of GGA3 stabilizes BACE and enhances betasecretase activity. Neuron. 2007;54:721–737. doi: 10.1016/j.neuron.2007.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Fasulo L., Ugolini G., Cattaneo A. Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K. J Alzheimers Dis. 2005;7:3–13. doi: 10.3233/jad-2005-7102. [DOI] [PubMed] [Google Scholar]
  • [50].Rissman R.A., Poon W.W., Blurton-Jones M., Oddo S., Torp R., Vitek M.P., et al. Caspase-cleavage of tau is an early event in Alzheimer’s disease tangle pathology. J Clin Invest. 2004;114:121–130. doi: 10.1172/JCI20640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Gamblin T.C., Chen F., Zambrano A., Abraha A., Lagalwar S., Guillozet A.L., et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2003;100:10032–10037. doi: 10.1073/pnas.1630428100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Arnold S.E., Louneva N., Cohen J.W., Han L.Y., Talbot K., Wilson R.S., et al. Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer’s disease. Am J Pathol. 2008;173:1488–1495. doi: 10.2353/ajpath.2008.080434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [53].Selkoe D.J., Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci. 2007;27:2866–2875. doi: 10.1523/JNEUROSCI.4970-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [54].Terry R.D., Masliah E., Salmon D.P., Butters N., Deteresa R., Hill R., et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572–580. doi: 10.1002/ana.410300410. [DOI] [PubMed] [Google Scholar]
  • [55].Turrigiano G. Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu Rev Neurosci. 2011;34:89–103. doi: 10.1146/annurev-neuro-060909-153238. [DOI] [PubMed] [Google Scholar]
  • [56].Shepherd J.D., Bear M.F. New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci. 2011;14:279–284. doi: 10.1038/nn.2708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [57].Turrigiano G.G., Nelson S.B. Thinking globally, acting locally: AMPA receptor turnover and synaptic strength. Neuron. 1998;21:933–935. doi: 10.1016/S0896-6273(00)80607-8. [DOI] [PubMed] [Google Scholar]
  • [58].Mattson M.P., Lu C.B., Fu W.M., Salvesen G.S. Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromolecular Med. 2002;1:69–79. doi: 10.1385/NMM:1:1:69. [DOI] [PubMed] [Google Scholar]
  • [59].Glazner G.W., Chan S.L., Lu C., Mattson M.P. Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J Neurosci. 2000;20:3641–3649. doi: 10.1523/JNEUROSCI.20-10-03641.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Liu S.J., Gasperini R., Foa L., Small D.H. Amyloid-beta decreases cellsurface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2. J Alzheimers Dis. 2010;21:655–666. doi: 10.3233/JAD-2010-091654. [DOI] [PubMed] [Google Scholar]
  • [61].Hyman B.T. Caspase activation without apoptosis: insight into Abeta initiation of neurodegeneration. Nat Neurosci. 2011;14:5–6. doi: 10.1038/nn0111-5. [DOI] [PubMed] [Google Scholar]
  • [62].Chang E.H., Savage M.J., Flood D.G., Thomas J.M., Levy R.B., Mahadomrongkul V., et al. AMPA receptor downscaling at the onset of Alzheimer’s disease pathology in double knockin mice. Proc Natl Acad Sci U S A. 2006;103:3410–3415. doi: 10.1073/pnas.0507313103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].Pratt K.G., Zimmerman E.C., Cook D.G., Sullivan J.M. Presenilin 1 regulates homeostatic synaptic scaling through Akt signaling. Nat Neurosci. 2011;14:1112–1114. doi: 10.1038/nn.2893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 1997;278:687–689. doi: 10.1126/science.278.5338.687. [DOI] [PubMed] [Google Scholar]
  • [65].Fernando P., Brunette S., Megeney L.A. Neural stem cell differentiation is dependent upon endogenous caspase 3 activity. FASEB J. 2005;19:1671–1673. doi: 10.1096/fj.04-2981fje. [DOI] [PubMed] [Google Scholar]
  • [66].Rohn T.T., Cusack S.M., Kessinger S.R., Oxford J.T. Caspase activation independent of cell death is required for proper cell dispersal and correct morphology in PC12 cells. Exp Cell Res. 2004;295(1):215–225. doi: 10.1016/j.yexcr.2003.12.029. [DOI] [PubMed] [Google Scholar]
  • [67].Mattson M.P., Partin J., Begley J.G. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 1998;807:167–176. doi: 10.1016/S0006-8993(98)00763-X. [DOI] [PubMed] [Google Scholar]
  • [68].Ivins K.J., Bui E.T., Cotman C.W. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol Dis. 1998;5:365–378. doi: 10.1006/nbdi.1998.0228. [DOI] [PubMed] [Google Scholar]
  • [69].Kuo C.T., Zhu S., Younger S., Jan L.Y., Jan Y.N. Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning. Neuron. 2006;51:283–290. doi: 10.1016/j.neuron.2006.07.014. [DOI] [PubMed] [Google Scholar]
  • [70].Mattson M.P., Duan W. “Apoptotic” biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J Neurosci Res. 1999;58:152–166. doi: 10.1002/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  • [71].Williams D.W., Kondo S., Krzyzanowska A., Hiromi Y., Truman J.W. Local caspase activity directs engulfment of dendrites during pruning. Nat Neurosci. 2006;9:1234–1236. doi: 10.1038/nn1774. [DOI] [PubMed] [Google Scholar]
  • [72].Lu C., Fu W., Salvesen G.S., Mattson M.P. Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromolecular Med. 2002;1:69–79. doi: 10.1385/NMM:1:1:69. [DOI] [PubMed] [Google Scholar]
  • [73].Sun C., Cai M., Gunasekera A.H., Meadows R.P., Wang H., Chen J., et al. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature. 1999;401:818–822. doi: 10.1038/44617. [DOI] [PubMed] [Google Scholar]
  • [74].Wilson R., Goyal L., Ditzel M., Zachariou A., Baker D.A., Agapite J., et al. The DIAP1 RING finger mediates ubiquitination of Dronc and is indispensable for regulating apoptosis. Nat Cell Biol. 2002;4:445–450. doi: 10.1038/ncb799. [DOI] [PubMed] [Google Scholar]
  • [75].Ditzel M., Broemer M., Tenev T., Bolduc C., Lee T.V., Rigbolt K.T., et al. Inactivation of effector caspases through nondegradative polyubiquitylation. Mol Cell. 2008;32:540–553. doi: 10.1016/j.molcel.2008.09.025. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neuroscience Bulletin are provided here courtesy of Springer

RESOURCES